A multi-center, open-label study to evaluate the long-term safety of weekly intravenous infusions of alpha1-proteinase inhibitor (human) in Japanese subjects with alpha1 antitrypsin deficiency (AATD)

Trial Profile

A multi-center, open-label study to evaluate the long-term safety of weekly intravenous infusions of alpha1-proteinase inhibitor (human) in Japanese subjects with alpha1 antitrypsin deficiency (AATD)

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 19 Apr 2017

At a glance

  • Drugs Alpha 1-antitrypsin (Primary)
  • Indications Alpha 1-antitrypsin deficiency
  • Focus Adverse reactions
  • Sponsors Grifols
  • Most Recent Events

    • 18 Apr 2017 Status changed from recruiting to active, no longer recruiting.
    • 01 Dec 2016 Status changed from not yet recruiting to recruiting.
    • 09 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top